Efek Imunomodulator Ekstrak Etanol Akar Pasak Bumi (Eurycoma Longifolia, Jack) terhadap Ekspresi CD57 pada Hepar Tikus yang Diberi Doksorubisin

Penulis

  • Nurma Wahyuningtyas Program Studi Magister Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Danang Prasetyaning Amukti Program Studi Magister Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Laela Hayu Nurani Program Studi Magister Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Nina Salamah Program Studi Magister Farmasi, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia Ahmad Dahlan Halal Center, Universitas Ahmad Dahlan, Yogyakarta, Indonesia

DOI:

https://doi.org/10.20527/jps.v11i2.18499

Kata Kunci:

Doxorubicin, Chemotherapy, Eurycoma longifolia, Anti-cancer, Hepatoprotector

Abstrak

Agen kemoterapi yang terbukti dapat menurunkan imunitas tubuh adalah doksorubisin. Akar pasak bumi (Eurycoma longifolia, Jack) telah digunakan untuk meningkatkan imunitas serta antikanker. CD57 merupakan suatu penanda diferensiasi terminal dan  disfungsi limfosit pada sel T CD8+, CD4+, dan NK sel. Studi ini menyelidiki efek EEAPB pada ekspresi CD57 hati mencit SD (Sprague Dawley) yang diberi doksorubisin. Dalam penelitian ini, 49 tikus dibagi menjadi 7 kelompok. Kelompok I sebagai kontrol doksorubisin, kelompok II sebagai kontrol EEAPB 200 mg/kgBB, dan kelompok III, IV, dan V sebagai kelompok perlakuan doksorubisin + EEAPB 50 mg/kgBB, 100 mg/kgBB, dan 200 mg/kgBB. Kelompok VI sebagai kontrol pelarut (CMC Na 1%), dan kelompok VII sebagai kontrol sehat. Penelitian dilanjutkan dengan pewarnaan hati tikus dengan imunohistokimia untuk mengidentifikasi ekspresi CD57, dan pengujian statistik dilakukan dengan SPSS. Seluruh kelompok perlakuan mempunyai efek penurunan % ekspresi CD57 secara signifikan dibandingkan dengan kelompok kontrol doksorubisin. Oleh karena itu, EEAPB dapat meningkatkan imunitas dengan menurunkan persentase ekspresi CD57 pada hati tikus strain SD yang telah diberikan doksorubisin secara signifikan dan dosis yang dapat menurunkan persentase ekspresi CD57 maksimal, yaitu 50 mg/Kg BB. Kata Kunci: Doksorubisin, Kemoterapi, Pasak Bumi, Anti kanker, Hepatoprotektor A chemotherapy agent that has been shown to lower immunity is doxorubicin. The root of pasak bumi (Eurycoma longifolia, Jack) has been used to boost immunity and as an anticancer. CD57 is a marker of terminal differentiation and lymphocyte dysfunction in CD8+, CD4+, and NK T cells. This study investigated the effect of EEAPB on liver CD57 expression of SD (Sprague Dawley) mice treated with doxorubicin. In this study, 49 mice were divided into seven groups. Group I as doxorubicin control, group II as EEAPB 200 mg/kgBB control, and groups III, IV, and V as doxorubicin + EEAPB 50 mg/kgBB, 100 mg/kgBB, and 200 mg/kgBB treatment groups. Group VI was used as solvent control (CMC Na 1%), and group VII was used as healthy control. The study was followed by staining the liver of mice with immunohistochemistry to identify CD57 expression, and statistical testing was performed with SPSS. All treatment groups had the effect of decreasing the % expression of CD57 compared to the doxorubicin control group. Therefore, EEAPB can improve immunity by reducing the percentage of CD57 expression in the liver of SD strain rats that have been given doxorubicin at a dose that reduces the maximum rate of CD57 expression, which is 50 mg/Kg BW.

Referensi

Agnello, L., d’Argenio, A., Nilo, R., Fedele, M., Camorani, S., & Cerchia, L. (2023). Aptamer-Based Strategies to Boost Immunotherapy in TNBC. In Cancers (Vol. 15, Issue 7). MDPI. https://doi.org/10.3390/cancers15072010

Al Aradi, A., Al Rashed, A. A., Mubarak, M., Hasan, O., Al Arayedh, A., Isa, Q. M., & Alaradi, H. (2022). Renal Carcinoma Patterns and Prevalence in Bahrain: A Descriptive Study. Cureus. https://doi.org/10.7759/cureus.31443

Anwar, K., Istiqamah, F., & Hadi, S. (2021). Optimasi Suhu dan Waktu Ekstraksi Akar Pasak Bumi (Eurycoma longifolia jack.) Menggunakan Metode RSM (response surface methodology) dengan Pelarut Etanol 70%. Jurnal Pharmascience, 8(1), 53. https://doi.org/10.20527/jps.v8i1.9085

Chatzileontiadou, D. S. M., Sloane, H., Nguyen, A. T., Gras, S., & Grant, E. J. (2020). Molecular Sciences The Many Faces of CD4 + T Cells: Immunological and Structural Characteristics. https://doi.org/10.3390/ijms

Christowitz, C., Davis, T., Isaacs, A., Van Niekerk, G., Hattingh, S., & Engelbrecht, A. M. (2019). Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-019-5939-z

Chung, H. K., Kim, J. T., Kim, H. W., Kwon, M., Kim, S. Y., Shong, M., Kim, K. S., & Yi, H. S. (2017). GDF15 deficiency exacerbates chronic alcohol- and carbon tetrachloride-induced liver injury. Scientific Reports, 7(1). https://doi.org/10.1038/s41598-017-17574-w

De Guzman, R., & Malik, M. (2019). Global Cancer Burden and Natural Disasters: A Focus on Asia’s Vulnerability, Resilience Building, and Impact on Cancer Care. In J Global Oncol.

Garg, S., Sharma, N., Bharmjeet, & Das, A. (2023). Unraveling the intricate relationship: Influence of microbiome on the host immune system in carcinogenesis. In Cancer Reports (Vol. 6, Issue 11). John Wiley and Sons Inc. https://doi.org/10.1002/cnr2.1892

Guyonnet, J. P., Cantarel, A. A. M., Simon, L., & Haichar, F. Z. (2018). Root exudation rate as functional trait involved in plant nutrient-use strategy classification. International Journal of Business Innovation and Research, 17(3), 8573–8581. https://doi.org/10.1002/ece3.4383

Hassouneh, F., Lopez-Sejas, N., Campos, C., Sanchez-Correa, B., Tarazona, R., Solana, R., & Pera, A. (2017). Differential effect of cytomegalovirus infection with age on the expression of CD57, CD300a, and CD161 on T-Cell subpopulations. Frontiers in Immunology, 8(JUN). https://doi.org/10.3389/fimmu.2017.00649

He, Q., Wang, F., Ryan, T. D., Chalasani, M., & Redington, A. N. (2020). Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity. JACC: CardioOncology, 2(1), 41–52. https://doi.org/10.1016/j.jaccao.2020.01.005

Hosseini, A., & Sahebkar, A. (2017). Reversal of doxorubicin-induced cardiotoxicity by using phytotherapy: A review. Journal of Pharmacopuncture, 20(4), 243–256. https://doi.org/10.3831/KPI.2017.20.030

Iwata, T., Miyauchi, A., Suga, Y., Nishio, H., Nakamura, M., Ohno, A., Hirao, N., Morisada, T., Tanaka, K., Ueyama, H., Watari, H., & Aoki, D. (2016). Neoadjuvant chemotherapy for locally advanced cervical cancer. In Chinese Journal of Cancer Research, 28(2), 235–240. https://doi.org/10.21147/j.issn.1000-9604.2016.02.13

Jaigirdar, S. A., & MacLeod, M. K. L. (2015). Development and function of protective and pathologic memory CD4 T cells. In Frontiers in Immunology, 6(SEP). https://doi.org/10.3389/fimmu.2015.00456

John, S., Joseph, A. P., Raghavan Pillai, V. B., Ramani, P., P, J., & Ramalingam, K. (2024). Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study. Cureus. https://doi.org/10.7759/cureus.56323

Muhamad, A. S., Ooi, F. K., & Chen, C. K. (2015). Effects of Eurycoma longifolia on Natural Killer Cells and Endurance Running Performance. International Journal of Sports Science, 5(3), 93–98. https://doi.org/10.5923/j.sports.20150503.01

Nie, J., Zhao, C., Deng, L., Chen, J., Yu, B., Wu, X., Pang, P., & Chen, X. (2016). Efficacy of traditional Chinese medicine in treating cancer (Review). Biomedical Reports, 4(1), 3–14. https://doi.org/10.3892/br.2015.537

Noval, & Raihana. (2019). Efek ekstrak etanol akar pasak bumi ( eurycoma longifolia , jack ) pada pemberian doxorubicin effects of pasak bumi roots (Eurycoma longifolia Jack.) extracts ethanolon the expression of hras in heart organs of galur mice. Jurnal Surya Medika, 5(1).

Nurani, L. H., Widyarini, S., & Mursyidi, A. (2015). Uji Sitotoksik dan Uji Kombinasi Fraksi Etil Asetat Ekstrak Etanol Akar Pasak Bumi (Eurycoma longifolia Jack.,) dan Doksorubisin pada Sel Limfosit. Journal of Tropical Pharmacy and Chemistry, 3(2), 138–147. https://doi.org/10.25026/jtpc.v3i2.100

Phetsouphanh, C., Xu, Y., & Zaunders, J. (2015). CD4 T cells mediate both positive and negative regulation of the immune response to HIV infection: Complex role of T follicular helper cells and regulatory T cells in pathogenesis. Frontiers in Immunology, 6(JAN). https://doi.org/10.3389/fimmu.2014.00681

Safithri, F. (2018). Mekanisme Regenerasi Hati secara Endogen pada Fibrosis Hati. MAGNA MEDIKA: Berkala Ilmiah Kedokteran, 2(4), 9–26.

Setiawan, I. M. A. (2023). Peran Pemeriksaan Imunohistokimia dalam Diagnosis dan Prognosis Kanker Payudara. Cermin Dunia Kedokteran, 50(8), 443-446. https://doi.org/10.55175/cdk.v50i8.667

Simonetta, F., Hua, S., Lécuroux, C., Gérard, S., Boufassa, F., Sáez-Cirión, A., Pancino, G., Goujard, C., Lambotte, O., Venet, A., & Bourgeois, C. (2014). High Eomesodermin Expression among CD57 + CD8 + T Cells Identifies a CD8 + T Cell Subset Associated with Viral Control during Chronic Human Immunodeficiency Virus Infection . Journal of Virology, 88(20), 11861–11871. https://doi.org/10.1128/jvi.02013-14

Yao, D., Xu, L., Liu, L., Zeng, X., Zhong, J., Lai, J., Zheng, R., Jin, Z., Chen, S., Zha, X., Huang, X., & Lu, Y. (2020). Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia. BioMed Research International, 2020. https://doi.org/10.1155/2020/9531549

Zhang, X.-Y., Li, W.-G., Wu, Y.-J., & Gao, M.-T. (2010). Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. Journal of Pharmacy and Pharmacology, 57(8), 1043–1051. https://doi.org/10.1211/0022357056523

Zhao, C., Wu, X., Chen, J., & Qian, G. (2022). The therapeutic effect of IL-21 combined with IFN-γ inducing CD4+CXCR5+CD57+T cells differentiation on hepatocellular carcinoma. Journal of Advanced Research, 36, 89–99. https://doi.org/10.1016/j.jare.2021.05.010

##submission.downloads##

Diterbitkan

2024-10-31

Terbitan

Bagian

Jurnal Pharmascience